PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics
02-Jul-2024 Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma Biotherapeutics, Inc.
01-Jul-2024 New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses Teva Pharmaceutical Industries Ltd
28-Jun-2024 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma AB
28-Jun-2024 Almirall’s Ilumetri® (tildrakizumab) restores and maintains wellbeing of patients with moderate-to-severe plaque psoriasis to the levels of the general population for up to 1 year[i] Almirall
28-Jun-2024 Lindus Health Launches Bespoke “All-in-One Medical Device CRO” Offering for Medical Device Clinical Trials Lindus Health
27-Jun-2024 NICE recommends CSL Behring’s HEMGENIX® (etranacogene dezaparvovec) as the first single infusion gene therapy for adults with severe or moderately severe haemophilia B without a history of FIX inhibitors for reimbursement via a managed access agreement, recognising the treatment as cost-effective in England. CSL Behring
27-Jun-2024 The Danish Medicines Council recommends CSL Behring’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B CSL Behring
27-Jun-2024 CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital CatSci Ltd
27-Jun-2024 Fostrox + Lenvima® holds promise of greatly improved outcomes for advanced liver cancer patients, reveals new data from Medivir at ESMO GI Medivir AB
27-Jun-2024 CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) CalciMedica Inc
27-Jun-2024 SMART Researchers Pioneer Production of CAR T-Cells Using High-Density Microfluidic Bioreactor SMART
26-Jun-2024 Discovery Park Innovation Summit showcases Kent’s ambition to be a leader in healthy ageing Discovery Park
26-Jun-2024 EDX MEDICAL TO MARKET PIONEERING CANCER DRUGS RESPONSE ASSAY IN UK AND NORDICS EDX Medical Group
26-Jun-2024 Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models Ikerian AG
25-Jun-2024 Engitix appoints two additional international biotech industry leaders as Scientific Advisors Engitix Ltd
25-Jun-2024 Emmes partners with ILiAD Biotechnologies to Conduct Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine ILiAD Biotechnologies, LLC
25-Jun-2024 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda HUTCHMED
25-Jun-2024 Senzime granted new European TetraGraph system patent Senzime
25-Jun-2024 Linus Health Introduces Person-Centered Approach to Establish Clinically Meaningful Benefits and Personalized Brain Health Care Linus Health